Cargando…

MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice

The tuberculosis (TB) vaccine MTBVAC is the only live-attenuated Mycobacterium tuberculosis (Mtb)-based vaccine in clinical development, and it confers superior protection in different animal models compared to the current vaccine, BCG (Mycobacterium bovis bacillus Calmette-Guérin). With the aim of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Broset, Esther, Saubi, Narcís, Guitart, Núria, Aguilo, Nacho, Uranga, Santiago, Kilpeläinen, Athina, Eto, Yoshiki, Hanke, Tomáš, Gonzalo-Asensio, Jesús, Martín, Carlos, Joseph-Munné, Joan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395831/ https://www.ncbi.nlm.nih.gov/pubmed/30859110 http://dx.doi.org/10.1016/j.omtm.2019.01.014

Ejemplares similares

MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic
por: Gonzalo-Asensio, Jesus, et al.
Publicado: (2017)

Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice
por: Kilpeläinen, Athina, et al.
Publicado: (2019)

Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice
por: Kilpeläinen, Athina, et al.
Publicado: (2019)

Preclinical development of BCG.HIVA(2auxo.int), harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity
por: Mahant, Aakash, et al.
Publicado: (2017)

Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c Mice
por: Saubi, Narcís, et al.
Publicado: (2020)

MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice
por: Aguilo, Nacho, et al.
Publicado: (2016)

Chimeric Human Papillomavirus-16 Virus-like Particles Presenting P18I10 and T20 Peptides from HIV-1 Envelope Induce HPV16 and HIV-1-Specific Humoral and T Cell-Mediated Immunity in BALB/c Mice
por: Chen, Chun-Wei, et al.
Publicado: (2022)

Expression of Chimeric HPV-HIV Protein L1P18 in Pichia pastoris; Purification and Characterization of the Virus-like Particles
por: Eto, Yoshiki, et al.
Publicado: (2021)

Engineering new mycobacterial vaccine design for HIV–TB pediatric vaccine vectored by lysine auxotroph of BCG
por: Saubi, Narcís, et al.
Publicado: (2014)

New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia
por: Tarancón, Raquel, et al.
Publicado: (2020)

Design Concepts of Virus-Like Particle-Based HIV-1 Vaccines
por: Chen, Chun-Wei, et al.
Publicado: (2020)

Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection
por: Dijkman, Karin, et al.
Publicado: (2021)

Evaluation of the immunogenicity and efficacy of BCG and MTBVAC vaccines using a natural transmission model of tuberculosis
por: Roy, Alvaro, et al.
Publicado: (2019)

Chimeric Human Papillomavirus-16 Virus-like Particles Presenting HIV-1 P18I10 Peptide: Expression, Purification, Bio-Physical Properties and Immunogenicity in BALB/c Mice
por: Chen, Chun-Wei, et al.
Publicado: (2023)

Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro–American genetic background confers optimal vaccine potential
por: Pérez, Irene, et al.
Publicado: (2020)

Pre-Clinical Development of BCG.HIVA(CAT), an Antibiotic-Free Selection Strain, for HIV-TB Pediatric Vaccine Vectored by Lysine Auxotroph of BCG
por: Saubi, Narcís, et al.
Publicado: (2012)

Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination
por: Vierboom, Michel P.M., et al.
Publicado: (2021)

Pre-clinical development of BCG.HIVA(CAT) strain, an antibiotic-free selection strain for HIV-TB pediatric vaccine
por: Saubi, N, et al.
Publicado: (2012)

Evolutionary Landscape of the Mycobacterium tuberculosis Complex from the Viewpoint of PhoPR: Implications for Virulence Regulation and Application to Vaccine Development
por: Broset, Esther, et al.
Publicado: (2015)

New insights into the transposition mechanisms of IS6110 and its dynamic distribution between Mycobacterium tuberculosis Complex lineages
por: Gonzalo-Asensio, Jesús, et al.
Publicado: (2018)

BCG vaccination improves DTaP immune responses in mice and is associated with lower pertussis incidence in ecological epidemiological studies
por: Broset, Esther, et al.
Publicado: (2021)

The Mycobacterium tuberculosis PhoPR virulence system regulates expression of the universal second messenger c-di-AMP and impacts vaccine safety and efficacy
por: Pérez, Irene, et al.
Publicado: (2022)

Engineering a new vaccine platform for heterologous antigen delivery in live-attenuated Mycobacterium tuberculosis
por: Broset, Esther, et al.
Publicado: (2021)

Granzyme A Is Expressed in Mouse Lungs during Mycobacterium tuberculosis Infection but Does Not Contribute to Protection In Vivo
por: Uranga, Santiago, et al.
Publicado: (2016)

Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis
por: Aguilo, Nacho, et al.
Publicado: (2017)

Newborn Mice Vaccination with BCG.HIVA(222) + MVA.HIVA Enhances HIV-1-Specific Immune Responses: Influence of Age and Immunization Routes
por: Saubi, Narcís, et al.
Publicado: (2011)

Independent genomic polymorphisms in the PknH serine threonine kinase locus during evolution of the Mycobacterium tuberculosis Complex affect virulence and host preference
por: Mata, Elena, et al.
Publicado: (2020)

TB/HIV : a clinical manual /
por: Harries, A. D.
Publicado: (2004)

Assessing the impact of TB/HIV services integration on TB treatment outcomes and their relevance in TB/HIV monitoring in Ghana
por: Ansa, Gloria Akosua, et al.
Publicado: (2012)

Incidence of socially significant infectious diseases (HIV, TB and HIV/TB coinfection) in the Arctic regions of Russia)
por: Zagdyn, Z., et al.
Publicado: (2021)

Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy
por: Perello, R., et al.
Publicado: (2019)

MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies
por: White, Andrew D., et al.
Publicado: (2021)

Microbiome dataset from the upper respiratory tract of patients living with HIV, HIV/TB and TB from Myanmar
por: Htun, Kyaw Soe, et al.
Publicado: (2018)

Confronting TB/HIV in the era of increasing anti-TB drug resistance
por: Chakaya, Jeremiah, et al.
Publicado: (2008)

TB or not TB? Difficulties in the diagnosis of tuberculosis in HIV-negative immigrants to Germany
por: Singh, DD, et al.
Publicado: (2011)

Molecular Characterization of Heterologous HIV-1gp120 Gene Expression Disruption in Mycobacterium bovis BCG Host Strain: A Critical Issue for Engineering Mycobacterial Based-Vaccine Vectors
por: Joseph, Joan, et al.
Publicado: (2010)

Therapeutic efficacy of pulmonary live tuberculosis vaccines against established asthma by subverting local immune environment
por: Tarancón, Raquel, et al.
Publicado: (2021)

Atripla(R)/anti-TB combination in TB/HIV patients. Drug in focus
por: Semvua, Hadija H, et al.
Publicado: (2011)

Linkage to Care and Treatment for TB and HIV among People Newly Diagnosed with TB or HIV-Associated TB at a Large, Inner City South African Hospital
por: Voss De Lima, Yara, et al.
Publicado: (2013)

HIV, TB, Malaria, Filaria and Kala azar
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_6e83hpjo6219egifsmltjdec6n